Mulya.ai
Ticker
DVA
Scenario
Key Inputs
Revenue est.?Analysttaper yr2
OP margin est.?Analyst
Reinvestment est.?avg_lt_ttm
R&D capitalizedNo
Leases factoredYes
Key Assumptions
WACC ?8.2%
ERP ?4.5%
Risk-free rate ?4.1%
Beta (blended) ?0.908
Beta (levered) ?1.472
Terminal OM% ?14.2%
Segment conc. ?100% dominant
Terminal growth ?4.1%
Bond rating ?A- · 1.45%
ROIC option ?Opt 2 · 13.1%
Prob of failure ?0.0%
Pipeline validated · 2026-07-21

DVA · DaVita Inc.

$217.042026-07-21
Sector: Healthcare; Industry: Medical - Care Facilities; Sub-Industry: Health Care Services

Intrinsic Value Range Comparison · Mulya.ai

Leases factored
Bull
$267
+23.1% vs market
Base · active
$206
-5.0% vs market
Bear
$206
-5.0% vs market
Mulya.ai vs Analyst IV Comparison?
Median $200
Bear $206
Base $206
Market $217
Bull $267
Market Price $217
Mulya.ai Base $206
Analysts Median $200
Mulya.ai IV range ($206 · $267)
Analysts Range ($190 · $220)
Fundamentals · historical + forward · base
italics = DCF projection
PeriodRevenueRev Gr ?Ops M% ?Tax Rate ?NOPAT ?
Reinvest ?
FCFF ?WACC% ?PV FCFF ?ROIC ?Inv. Cap ?EPS ?P/E
2024.Q1$12.1B14.3%18.1%$1.4B−$2.4B−$980MM8.2%12.0%$11.8B$10.04
2024.Q4$12.1B0.0%14.3%18.3%$1.4B−$1.8B−$384MM8.3%12.5%$10.8B$10.04
2025.Q1$12.8B5.6%17.7%18.5%$1.8B−$1.9B−$60MM8.8%16.4%$11.6B$13.59
2025.Q4$12.8B0.0%17.7%21.8%$1.8B−$2.5B−$743MM8.1%14.0%$13.6B$13.59
2026.Q1$13.8B8.0%16.2%21.8%$1.8B−$2.2B−$479MM8.5%13.8%$11.7B$11.356.7
italics below = DCF projection · 10yr Rev CAGR: 3.4%
2027.Q1$14.2B+2.6%16.1%21.6%$1.8B−$318MM$1.5B8.2%$1.4B15.1%$12.1B$24.029.0
2028.Q1$14.6B+2.8%17.8%21.4%$2.0B−$355MM$1.7B8.3%$1.4B16.7%$12.4B$27.477.9
2029.Q1$15.0B+3.0%18.5%21.2%$2.2B−$396MM$1.8B8.3%$1.4B17.3%$12.8B$29.357.4
2030.Q1$15.6B+3.5%18.5%21.1%$2.3B−$487MM$1.8B8.3%$1.3B17.4%$13.3B$30.437.1
2031.Q1$16.1B+3.8%18.5%20.9%$2.4B−$561MM$1.8B8.4%$1.2B17.4%$13.9B$31.646.9
Term. Yr+$20.2B4.1%14.2%20.0%$2.3B−$716MM$1.6B8.6%$15.6B13.1%
Active scenario IV: $206 (-5.0% vs market)